Lewis T. Williams, M.D., Ph.D.

Lewis T. Williams, M.D., Ph.D.

DirectoratProtagonist Therapeutics· In proxies 2023–2025

Lewis T. Williams, M.D., Ph.D. sits on 5 public boards.

Boards1

  • Protagonist TherapeuticsDirector · 8 yr on the boardIndependentCompensation, Research—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Protagonist TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +1,307%
  2. ReAlta Life SciencesPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Ten30 BioPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  4. Nasdaq: NLTX)Public company
    • Director? – PresentNo stock prices for these years
  5. Neoleukin Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?